Dotbio
DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit
7-day free trial · no credit card
Verified contacts
16
available on Kipplo
LinkedIn employees
22
1 to 10 range
Open roles
—
no listings
Distinct roles
10
indexed titles
Tech stack
2
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 16 verified contacts at Dotbio
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
16 contacts with verified email or phone · masked until revealed.
Showing 1 of 16 verified contacts
Top roles at Dotbio
10 distinct titles indexed · top 10 shown.
- 3scientist
- 2project manager
- 2research associate
- 1advisor
- 1business development executive
- 1chief operating officer
- 1intern
- 1research and development intern
- 1research associate (validation)
- 1senior scientist
Sign up to unlock all 16 contacts at Dotbio
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 16 verified contacts at Dotbio
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.